Andreas Schwingshackl, MD, PhD | American Lung Association

Location Select your location

Andreas Schwingshackl, MD, PhD

Research Awards Nationwide Recipient (2013-2015)

University of Tennessee Health Science Center
Funded in Partnership with the American Lung Association of the Midland States
Identifying New Targets to Treat Acute Lung Injury

Mechanical ventilation and oxygen therapy are common treatment options for acute lung injury (ALI), alt-hough both therapies are known to cause further damage to the lungs. Recent studies suggest that a particu-lar type of ion channel, 2-pore domain potassium (K2P), can sense signals at the cell membrane and convert them into specific cellular functions. The central hypothesis of this proposal is that the K2P channel is regulated by the treatments above and, in turn, regulates the release of inflammatory mediators. Dr. Schwingshackl and team hope to identify these channels as new potential targets for the development of novel treatment strategies against ALI.

Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.